Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Appeals Court Upholds Dismissal of Fosamax Lawsuit November 12, 2010 Staff Writers Add Your Comments A federal appeals court has upheld the dismissal of a Fosamax lawsuit last year, which was originally selected as one of the early bellwether trial in the federal multidistrict litigation (MDL). In an opinion issued on November 5 by the U.S. Court of Appeals for the Second Circuit, the trial court’s decision to grant summary judgment in a case filed by 74 year-old Bessie Flemings was affirmed. Last November, U.S. District Judge John Keenan, who is presiding over pretrial proceedings in the federal Fosamax litigation, ruled that Flemings would be unable to establish at trial that she developed osteonecrosis of the jaw (ONJ) from Fosamax. Learn More About Fosamax Lawsuit Side effects of Fosamax linked to a risk of sudden femur fractures, severe jaw damage and other problems. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Learn More About Fosamax Lawsuit Side effects of Fosamax linked to a risk of sudden femur fractures, severe jaw damage and other problems. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Flemings’ suit alleged that she suffers debilitating jaw damage from side effects of Fosamax, where portions of her jawbone have deteriorated and decayed. Judge Keenan’s dismissal was issued after Flemings’ dentist testified during deposition that he did not know what caused her develop osteonecrosis of the jaw, or ONJ. The Second Circuit Court of Appeals agreed with Judge Keenan, noting that Flemings had been a smoker since the age of eight, and currently smoked three packs a day, which her own dentist said could have caused the jaw problems. The Court found that Flemings had no witnesses who could definitively testify that Fosamax caused her jaw problems. Fosamax (alendronate sodium) is a member of a class of drugs known as bisphosphonates, which have been associated with decay of the jawbone when taken long-term or at high doses. With a very long half-life of 10 years, most of the Fosamax claims argue that dose accumulation over time increases the risk of ONJ. Fosamax was approved by the FDA in October 1995, and has been used by more than 20 million people. Before the medication became available as a generic last year, Fosamax sales generated more than $3 billion annually for Merck. There are currently about 1,400 pending Fosamax lawsuits filed by plaintiffs throughout the United States. Although the federal cases have been consolidated in an MDL, each plaintiff must establish that their individual jaw injury was caused by Fosamax. Flemings’ case was selected as one of three initial Fosamax bellwether cases, with trial scheduled to begin in January 2010. During complex litigation, a handful of cases are often selected for early trials to help the parties gauge how juries are likely to respond to evidence and testimony that will be presented in other cases. Bellwether trials are designed to facilitate a resolution for the litigation and a possible Fosamax settlement agreement for other cases. The first Fosamax bellwether trial, involving a claim brought by Shirley Boles, ended in a mistrial in September 2009, only a few weeks before Flemings’ case was dismissed. The Boles case was retried in June 2010, and a jury awarded Boles $8 million in damages. However, Judge Keenan later ruled that the damages awarded in the Fosamax suit were excessive, and plaintiffs have elected to have a new trial on the issue of compensation instead of accepting the Court’s reduced award of $1.5 million. After Flemings’ case was dismissed, the second bellwether Fosamax trial began in April 2010 involving a claim brought by Louise H. Maley. That lawsuit ended in a defense verdict in favor of Merck after the jury found that the plaintiff did not suffer osteonecrosis of the jaw from Fosamax. A third trial is currently underway in the U.S. District Court for the Southern District of New York, involving a claim brought by Judith Graves. According to an Order issued by Judge Keenan in September, at least two additional cases will be selected for bellwether trials next year, with the fourth trial to begin in March 2011 and the fifth trial in May 2011. If an agreement to settle Fosamax lawsuits is not reached following those trials, Judge Keenan may recommend that hundreds of cases be remanded back to District Courts throughout the United States for individual trials. Tags: Alendronate, Alendronate Sodium, Bisphosphonates, Fosamax, Merck, ONJ, Osteonecrosis of the Jaw Image Credit: | More Fosamax Lawsuit Stories Fosamax Fracture Lawsuits Dismissed Again, After Judge Rules FDA Rejected Label Warning Change March 24, 2022 Zometa Side Effects Increase Risk of Osteonecrosis of the Jaw: Study January 14, 2021 Study Questions Whether Fosamax And Similar Bone Drugs Provide Benefits After Seven Years of Use December 10, 2020 1 Comments Ylona July 28, 2012 well there are alot of bad doctors as well that fraud the ssteym which have skyrocketted costs due to lawsuits etc. its vicous circle, that in the end only makes it harder for us to get the medical attention we need. For sakes 2 weeks in a hospital costs as much as a condo. Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermPhoneThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES BioZorb Implant Removal Surgery: What Women Need To Know When the Device Fails To Dissolve (Posted: today) Following a Class I recall, more than 100 BioZorb lawsuits have been filed by breast cancer survivors who suffered painful complications after the surgical tissue marker failed to dissolve as intended. MORE ABOUT: BIOZORB LAWSUITLawsuit Claims Biozorb Implant Penetrated Skin, Causing Massive Infection (06/04/2025)Breast Cancer Survivors File BioZorb Tissue Marker Lawsuit After Implant Fails (05/20/2025)BioZorb Implant Lawsuit Alleges Tissue Marker Caused Swelling, Fluid Buildup and Chronic Pain (05/14/2025) Whippet Lawsuit Alleges Nitrous Oxide Addiction Resulted in Paralysis, Nerve Damage (Posted: 3 days ago) A class action lawsuit claims nitrous oxide canisters sold under names like GreatWhip and Galaxy Gas were illegally marketed for recreational use, leading to widespread addiction, nerve damage and paralysis among young users. MORE ABOUT: NITROUS OXIDE LAWSUITGalaxy Gas Class Action Lawsuit Over Deceptive Marketing of Nitrous Oxide Amended (06/16/2025)FDA Updates List of Nitrous Oxide Inhalant Products That Pose Serious Health Risks (06/06/2025)Nitrous Oxide Addiction Lawsuit Claims Manufacturer Concealed Galaxy Gas Side Effects (05/01/2025) Cartiva Settlement Rumors Mount Again, as More Toe Implant Lawsuits Withdrawn and Trials Approach (Posted: 4 days ago) The withdrawal of two Cartiva toe implant lawsuits has sparked rumors of a potential settlement agreement to resolve product liability claims over the recalled devices. MORE ABOUT: CARTIVA IMPLANT LAWSUITFailed Cartiva Implant Resulted in Need for Removal, Big Toe Fusion Surgery: Lawsuit (04/10/2025)Cartiva SCI Lawsuit Alleges Toe Implant Worsened Pain, Decreased Range of Motion (03/31/2025)Cartiva Implant Injury Lawsuit Set for Trial in February 2026 (03/07/2025)
Fosamax Fracture Lawsuits Dismissed Again, After Judge Rules FDA Rejected Label Warning Change March 24, 2022
Study Questions Whether Fosamax And Similar Bone Drugs Provide Benefits After Seven Years of Use December 10, 2020
BioZorb Implant Removal Surgery: What Women Need To Know When the Device Fails To Dissolve (Posted: today) Following a Class I recall, more than 100 BioZorb lawsuits have been filed by breast cancer survivors who suffered painful complications after the surgical tissue marker failed to dissolve as intended. MORE ABOUT: BIOZORB LAWSUITLawsuit Claims Biozorb Implant Penetrated Skin, Causing Massive Infection (06/04/2025)Breast Cancer Survivors File BioZorb Tissue Marker Lawsuit After Implant Fails (05/20/2025)BioZorb Implant Lawsuit Alleges Tissue Marker Caused Swelling, Fluid Buildup and Chronic Pain (05/14/2025)
Whippet Lawsuit Alleges Nitrous Oxide Addiction Resulted in Paralysis, Nerve Damage (Posted: 3 days ago) A class action lawsuit claims nitrous oxide canisters sold under names like GreatWhip and Galaxy Gas were illegally marketed for recreational use, leading to widespread addiction, nerve damage and paralysis among young users. MORE ABOUT: NITROUS OXIDE LAWSUITGalaxy Gas Class Action Lawsuit Over Deceptive Marketing of Nitrous Oxide Amended (06/16/2025)FDA Updates List of Nitrous Oxide Inhalant Products That Pose Serious Health Risks (06/06/2025)Nitrous Oxide Addiction Lawsuit Claims Manufacturer Concealed Galaxy Gas Side Effects (05/01/2025)
Cartiva Settlement Rumors Mount Again, as More Toe Implant Lawsuits Withdrawn and Trials Approach (Posted: 4 days ago) The withdrawal of two Cartiva toe implant lawsuits has sparked rumors of a potential settlement agreement to resolve product liability claims over the recalled devices. MORE ABOUT: CARTIVA IMPLANT LAWSUITFailed Cartiva Implant Resulted in Need for Removal, Big Toe Fusion Surgery: Lawsuit (04/10/2025)Cartiva SCI Lawsuit Alleges Toe Implant Worsened Pain, Decreased Range of Motion (03/31/2025)Cartiva Implant Injury Lawsuit Set for Trial in February 2026 (03/07/2025)